✦ LIBER ✦

Non-peptide αvβ3 antagonists: Identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint

✍ Scribed by James J Perkins; L.T Duong; Carmen Fernandez-Metzler; George D Hartman; Donald B Kimmel; Chih-Tai Leu; Joseph J Lynch; Thomayant Prueksaritanont; Gideon A Rodan; Sevgi B Rodan; Mark E Duggan; Robert S Meissner

Book ID: 108073116
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 143 KB
Volume: 13
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2003.09.055

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-Peptide αvβ3 Antagonists: Identifica

Non-Peptide αvβ3 Antagonists: Identification of Potent, Chain-Shortened EGD Mimetics that Incorporate a Central Pyrrolidinone Constraint.

✍ James J. Perkins; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 69 KB

Nonpeptide αvβ3 Antagonists: Identificat

Nonpeptide αvβ3 Antagonists: Identification of Potent, Chain-Shortened 7-Oxo RGD Mimetics.

✍ Amy E. Zartman; Le T. Duong; Carmen Fernandez-Metzler; George D. Hartman; Chih-T 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 20 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

Non-peptide αvβ3 Antagonists. Part 4. Po

Non-peptide αvβ3 Antagonists. Part 4. Potent and Orally Bioavailable Chain-Shortened RGD Mimetics.

✍ Paul J. Coleman; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB

Non-Peptide αvβ3 Antagonists. Part 5. Id

Non-Peptide αvβ3 Antagonists. Part 5. Identification of Potent RGD Mimetics Incorporating 2-Aryl β-Amino Acids as Aspartic Acid Replacements.

✍ Karen M. Brashear; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 88 KB

ChemInform Abstract: Non-Peptide αvβ3 An

ChemInform Abstract: Non-Peptide αvβ3 Antagonists. Part 3. Identification of Potent RGD Mimetics Incorporating Novel β-Amino Acids as Aspartic Acid Replacements.

✍ Paul J. Coleman; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB